• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Silvergate Capital Corporation

    7/30/25 11:00:13 AM ET
    $SI
    Medical/Dental Instruments
    Health Care
    Get the next $SI alert in real time by email
    8-A12B 1 shoulder-8xa12bjuly2025.htm 8-A12B Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-A
    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
    PURSUANT TO SECTION 12(b) OR (g) OF
    THE SECURITIES EXCHANGE ACT OF 1934
    SHOULDER INNOVATIONS, INC.
    (Exact name of registrant as specified in its charter)  
    Delaware
    (State or other jurisdiction of incorporation or organization)
    27-0538764
    (I.R.S. Employer Identification Number)
    1535 Steele Avenue SW, Suite B
    Grand Rapids, Michigan
    (Address of principal executive offices)
    49507
    (Zip Code)
    Securities to be registered pursuant to Section 12(b) of the Act:
    Title of each class
    to be so registered
    Name of each exchange on which
    each class is to be registered
    Common Stock, par value $0.001 per shareNew York Stock Exchange
    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box: ☒
    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box: ☐
    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
    Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333- 288549.
    Securities to be registered pursuant to Section 12(g) of the Act: None.



    Item 1. Description of Registrant’s Securities to be Registered.
    The description of the common stock, par value $0.001 per share, of Shoulder Innovations, Inc. (the “Company”), as included under the caption “Description of Capital Stock” in the prospectus forming a part of the Company’s Registration Statement on Form S-1, initially filed with the Securities and Exchange Commission (the “SEC”) on July 7, 2025 (File No. 333-288549) and as subsequently amended (the “Registration Statement”) is hereby incorporated by reference herein. In addition, the above-referenced description included in any prospectus relating to the Registration Statement filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
    Item 2. Exhibits.
    Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed hereunder because no other securities of the Company are registered on The New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.



    SIGNATURE
    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
    Date: July 30, 2025
    Shoulder Innovations, Inc.
    By:
    /s/ Robert Ball
    Name:
    Robert Ball
    Title:
    Chief Executive Officer

    Get the next $SI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SI

    DatePrice TargetRatingAnalyst
    8/25/2025$20.00Buy
    Goldman
    8/25/2025$23.00Buy
    BTIG Research
    8/25/2025$18.00Overweight
    Piper Sandler
    8/25/2025$19.00Buy
    Jefferies
    3/6/2023Neutral → Sell
    Compass Point
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    3/2/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. bought $29,632 worth of shares (2,000 units at $14.82), increasing direct ownership by 4% to 54,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    12/15/25 4:57:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $107,009 worth of shares (7,200 units at $14.86), increasing direct ownership by 6% to 118,457 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    12/15/25 4:51:45 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $25,072 worth of shares (1,600 units at $15.67), increasing direct ownership by 40% to 52,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:25:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

    GRAND RAPIDS, Mich., Feb. 3, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on Tuesday, February 10, 2026 and Wednesday, February 11, 2026.  About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusivel

    2/3/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Impulse Dynamics® Announces New Chief Financial Officer

    MARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment of Richard J. Buchholz as its new Chief Financial Officer (CFO), effective March 2, 2026. "Rick is an accomplished executive with a proven track record in the medical device industry," said Jason Spees, Chief Executive Officer at Impulse Dynamics®. "I am thrilled to welcome Rick to the Impulse Dynamics® team at a time when we are poised for our next phase of growth as we continue to advance our mission of improving patients' lives." Buchholz most recently served as the CFO for Inspire Medi

    1/13/26 9:00:00 AM ET
    $INSP
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

    Partnership will Expand Shoulder Innovations' Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Management to Participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference Today at 8:30 a.m. ET GRAND RAPIDS, Mich., Dec. 3, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-s

    12/3/25 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    SEC Filings

    View All

    Shoulder Innovations Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    12/3/25 7:10:53 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Shoulder Innovations Inc.

    10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    11/12/25 4:10:24 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    11/12/25 9:13:28 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Shoulder Innovations with a new price target

    Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Shoulder Innovations with a new price target

    BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & Executive Chairman Ball Robert Joseph exercised 12,062 shares at a strike of $2.42, increasing direct ownership by 5% to 276,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/10/26 4:24:26 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Financial Officer Points Jeffrey S.

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/3/26 4:43:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Officer Blue David Lawrence

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/3/26 4:39:36 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    5/22/23 4:03:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 4:49:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Leadership Updates

    Live Leadership Updates

    View All

    Silvergate announces changes to its executive team

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod

    11/7/22 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Mary-Margaret Henke to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial

    9/19/22 4:15:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Rebecca Rettig to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Rebecca Rettig to the board of directors for both the Company and its subsidiary bank, Silvergate Bank. "I am honored to join Silvergate's board at this moment of evolution in the bank's history and the digital asset ecosystem," said Rebecca Rettig. "I look forward to working with Silvergate's leadership and my fellow board members to strengthen the Company's leadership position in this evolving and innovative industry." "Rebecca's broad wealth of knowledge in the blockchain and

    3/16/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Financials

    Live finance-specific insights

    View All

    Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025

    GRAND RAPIDS, Mich., Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on November 11, 2025. Those interested in listening to the conference call may do so by dialing (877) 407-8216 fo

    10/20/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

    Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea

    8/28/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Suspends Series A Preferred Stock Dividend

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th

    1/27/23 6:55:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care